Image

Monitoring Arm Recovery After Stroke (MARS)

Monitoring Arm Recovery After Stroke (MARS)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

People who have a stroke often find it hard to do the things they did before. This can be caused by problems with arm movement. One in five people do not get any arm movement back after a stroke.

Arm movements can be measured accurately in a laboratory, but it is very expensive and not easy to do in hospital. That means it is hard to tell if the arm is recovering to move like it did before the stroke or adapting to perform tasks in other ways.

To tell if a treatment is working, the investigators are making a phone app to record arm movement, using the camera. The recordings will be turned into data showing movement difficulties and sent to hospital records for clinicians. Clinicians will see if movement changes, to help choose the best treatment.

The investigators are looking for twelve stroke survivors to help test this app.

  • The session will be at King's College London, on Guy's Campus.
  • It will run for 2-3 hours.
  • Participants will wear a vest or tight-fitting clothes.
  • The investigators will place non-invasive markers on the participants arm.
  • The investigators will video simple movements such as drinking from a cup.
  • The investigators will also measure the same simple movements using the laboratory cameras.

This will show us if our app can measure arm movement as well as laboratory tests. If they do, the investigators will know the app is accurate.

In future this technology can improve recovery by correcting stroke survivors when they perform home exercises.

Description

Upper limb recovery after stroke remains poor and 20% of stroke survivors do not recover arm movement. To improve outcome and advance insights to recovery mechanisms, an international collaboration has proposed a standardised set of outcome measures, including movement kinematics. Kinematics are moresensitive to change than clinical measures and can differentiate whether recovery is achieved by compensating to impairment or true recovery. However, kinematic assessments are not performed in clinical practice as 3-D motion capture requires expensive equipment and expertise for set-up and analysis.

The investigators therefore aim to develop a low-cost tool to measure kinematics. Open-source Artificial Intelligence models can detect positions and orientations on video and are called pose estimation models. The objectives will be to deploy and test these models in stroke survivors. The investigators will invite 12 stroke survivors with mild to moderate upper limb impairment and compare the accuracy of the models to gold-standard kinematic analysis when performing a variety of upper limb tasks. The investigators will optimise the models in case of any discrepancies. The investigators will develop a front-end smartphone app to instruct, record and provide feedback of arm movement performance to clinicians and stroke survivors. The investigators will develop the software back-end performing analysis of recorded movements and integrating these findings into electronic healthcare records for longitudinal performance tracking.

This accessible technology will provide clinicians kinematic analyses. Kinematics can guide treatment modifications and progression to improve upper limb movement.

Eligibility

Stroke survivors

Inclusion Criteria:

  • History of stroke
  • Arm impairment evidenced by Fugl-Meyer Upper Limb Assessment between 9-60/66.

Exclusion Criteria:

  • Severe cognitive impairment preventing ability to consent to treatment and understand and follow research protocol
  • Severe language deficit preventing ability to consent to treatment and understand and follow research protocol
  • Shoulder pain >3/10 on visual analog scale
  • Unable to maintain independent sitting balance without a high back support.
  • Wheelchair users that are unable to transfer with assistance of 1 to lab chair or whose wheelchair backrest cannot colapse.

Study details
    Stroke

NCT07016295

King's College London

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.